EA201391627A1 - Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения - Google Patents

Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения

Info

Publication number
EA201391627A1
EA201391627A1 EA201391627A EA201391627A EA201391627A1 EA 201391627 A1 EA201391627 A1 EA 201391627A1 EA 201391627 A EA201391627 A EA 201391627A EA 201391627 A EA201391627 A EA 201391627A EA 201391627 A1 EA201391627 A1 EA 201391627A1
Authority
EA
Eurasian Patent Office
Prior art keywords
protein
analysis
lyzyloxidase
availability
methods
Prior art date
Application number
EA201391627A
Other languages
English (en)
Russian (ru)
Inventor
Виктория СМИТ
Джоан И. Адамкевич
Сьюзан К. Лиман
Джейсон Чиен
Сяомин Ли
Лисинь Шао
Джеффри Д. Борнстейн
Original Assignee
Джилид Байолоджикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201391627(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Джилид Байолоджикс, Инк. filed Critical Джилид Байолоджикс, Инк.
Publication of EA201391627A1 publication Critical patent/EA201391627A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
EA201391627A 2011-06-01 2012-06-01 Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения EA201391627A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21
PCT/US2012/040585 WO2012167181A1 (en) 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof

Publications (1)

Publication Number Publication Date
EA201391627A1 true EA201391627A1 (ru) 2014-08-29

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391627A EA201391627A1 (ru) 2011-06-01 2012-06-01 Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения

Country Status (25)

Country Link
US (3) US20120309020A1 (https=)
EP (1) EP2714744A1 (https=)
JP (3) JP2014523521A (https=)
KR (1) KR20140048156A (https=)
CN (1) CN103946241A (https=)
AP (1) AP2013007285A0 (https=)
AR (1) AR086657A1 (https=)
AU (2) AU2012261883A1 (https=)
BR (1) BR112013030682A2 (https=)
CA (1) CA2837534A1 (https=)
CL (1) CL2013003445A1 (https=)
CO (1) CO6940375A2 (https=)
CR (1) CR20130657A (https=)
EA (1) EA201391627A1 (https=)
EC (1) ECSP13013092A (https=)
IL (1) IL229631A0 (https=)
MA (1) MA35212B1 (https=)
MD (1) MD20130098A2 (https=)
MX (1) MX2013013905A (https=)
PE (1) PE20141450A1 (https=)
PH (1) PH12013502490A1 (https=)
TW (1) TW201319572A (https=)
UY (1) UY34115A (https=)
WO (1) WO2012167181A1 (https=)
ZA (1) ZA201308812B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2700141T3 (es) 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
SG178845A1 (en) 2009-08-21 2012-04-27 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
SG11201503065PA (en) * 2012-10-30 2015-05-28 Gilead Sciences Inc Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
KR20170018383A (ko) * 2014-06-11 2017-02-17 길리애드 사이언시즈, 인코포레이티드 심혈관 질환의 치료 방법
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
AU2017228371A1 (en) 2016-03-04 2018-09-13 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
EP3440113A1 (en) 2016-04-08 2019-02-13 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2700141T3 (es) * 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
NZ625850A (en) * 2009-08-21 2015-12-24 Gilead Biologics Inc Methods and compositions for treatment of pulmonary fibrotic disorders
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
WO2012154432A2 (en) * 2011-05-10 2012-11-15 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
US20170269085A1 (en) 2017-09-21
ZA201308812B (en) 2014-08-27
PE20141450A1 (es) 2014-11-06
TW201319572A (zh) 2013-05-16
PH12013502490A1 (en) 2014-01-20
AP2013007285A0 (en) 2013-11-30
ECSP13013092A (es) 2014-08-29
UY34115A (es) 2013-01-03
NZ618682A (en) 2016-04-29
CA2837534A1 (en) 2012-12-06
CN103946241A (zh) 2014-07-23
AU2016244254A1 (en) 2016-11-03
MD20130098A2 (ro) 2014-06-30
CL2013003445A1 (es) 2014-07-25
IL229631A0 (en) 2014-01-30
AU2012261883A1 (en) 2013-05-02
EP2714744A1 (en) 2014-04-09
JP2014523521A (ja) 2014-09-11
KR20140048156A (ko) 2014-04-23
MA35212B1 (fr) 2014-06-02
WO2012167181A1 (en) 2012-12-06
JP2016164578A (ja) 2016-09-08
AU2016244254B2 (en) 2018-10-18
CO6940375A2 (es) 2014-05-09
MX2013013905A (es) 2014-05-14
JP2018049033A (ja) 2018-03-29
AR086657A1 (es) 2014-01-15
US20140206017A1 (en) 2014-07-24
CR20130657A (es) 2014-05-16
BR112013030682A2 (pt) 2016-12-06
US20120309020A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
EA201992748A1 (ru) Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
BR112014031365A2 (pt) métodos de detectar doenças ou condições
EP2583100A4 (en) ROTORS FOR IMMUNOASSAYS
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
WO2007114986A3 (en) Cooperative probes and methods of using them
MX336109B (es) Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo.
EA201400873A1 (ru) Механическая промывка и измерительный прибор для выполнения анализов
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2016198833A3 (en) Methods for analysing a urine sample
ATE551055T1 (de) Nachweis von succinylaceton
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
WO2017161363A8 (en) Point-of-care device for the colorimetric determination of hemoglobin and glucose-6-phosphate dehydrogenase in biological samples
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
BR112014000219A2 (pt) dispositivo de ensaio para a detecção de uma enzima ativa em uma amostra, método de determinação de presença e dos níveis de uma enzima ativa em uma amostra, kit, dispositivo de ensaio, ou método de uso ou o uso do mesmo e uso
BR112012021878A2 (pt) método para detectar um deriva de clorofila livre de fitol em uma amostra, método de análise para determinar a quantidade de atividade de enzina em uma amostra e kit para determinar a quantidade de atividade de enzima em uma amostra
MX2019000591A (es) Tira mejorada de ensayo de analisis de orina de bajo volumen de muestra, kits analiticos y metodos de uso relacionados con la misma.
WO2014151290A3 (en) Assay for predictive biomarkers